Research

Why the Coronavirus More Often Strikes Children of Color

Wed, 2020-09-02 22:17 — mike kraft

One of the notable features of the new coronavirus, evident early in the pandemic, was that it largely spared children. Some become severely ill, but deaths have been few, compared to adults.

But people of color have been disproportionately affected by Covid-19, the illness caused by the coronavirus, and recent studies have renewed concern about the susceptibility of children in these communities.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Problem

Situation Report

Read more about Why the Coronavirus More Often Strikes Children of Color
Log in or register to post comments

Symptoms can last much longer than expected--CDC study

Wed, 2020-09-02 21:56 — mike kraft

Coronavirus Disease 2019 (COVID-19) CDC provides credible COVID-19 health information to the U.S. CDC Centers for Disease Control and Prevention

(CNN) The US Centers for Disease Control and Prevention has said most people who tested positive for Covid-19 can return to work or school 10 days after the onset of symptoms, unless the illness requires hospitalization.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Symptoms can last much longer than expected--CDC study
1 comment
Log in or register to post comments

Steroids cut death rates among critically ill COVID-19 patients, major study finds

Wed, 2020-09-02 21:34 — mike kraft

Steroids cut death rates among critically ill COVID-19 patients, major study finds Treating critically ill COVID-19 patients with corticosteroid drugs reduces the risk of death by 20%, an analysis of seven international trials found on Wednesday, prompting the World Health Organisation to update its advice on treatment. Kate Kelland U.S.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Steroids cut death rates among critically ill COVID-19 patients, major study finds
Log in or register to post comments

NIH panel says plasma should not yet be considered standard care for cornonavirus

Wed, 2020-09-02 06:48 — mike kraft

Plasma should not be considered standard care for coronavirus, NIH panel says Convalescent plasma taken from Covid-19 survivors should not be considered a standard of care for coronavirus, an NIH panel says. Maggie Fox, CNN CNN

CNN)A National Institutes of Health panel said there's no evidence backing the use of convalescent plasma to treat coronavirus patients and that doctors should not treat it as a standard of care until more study has been done.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about NIH panel says plasma should not yet be considered standard care for cornonavirus
Log in or register to post comments

Large antibody study offers hope for virus vaccine efforts

Wed, 2020-09-02 04:22 — mike kraft

Large antibody study offers hope for virus vaccine efforts Antibodies that people make to fight the new coronavirus last for at least four months after diagnosis and do not fade quickly as some earlier reports suggested, scientists have... AP NEWS

Antibodies that people make to fight the new coronavirus last for at least four months after diagnosis and do not fade quickly as some earlier reports suggested, scientists have found.

Tuesday’s report, from tests on more than 30,000 people in Iceland, is the most extensive work yet on the immune system’s response to the virus over time, and is good news for efforts to develop vaccines.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Solutions

Read more about Large antibody study offers hope for virus vaccine efforts
Log in or register to post comments

AstraZeneca's coronavirus vaccine becomes third to begin Phase three trials in the United States

Tue, 2020-09-01 19:35 — mike kraft

AstraZeneca's coronavirus vaccine becomes third to begin Phase three trials in the United States British drugmaker AstraZeneca says it has started Phase 3 trials of its coronavirus vaccine candidate in the United States. The vaccine, AZD 1222, is the third to enter large-scale trials in the United States, after vaccines made by Moderna and Pfizer/BioNTech. Andrea Kane, CNN CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about AstraZeneca's coronavirus vaccine becomes third to begin Phase three trials in the United States
Log in or register to post comments

IN DEPTH: U.S. Will Revive Global Virus-Hunting Effort Ended Last Year

Mon, 2020-08-31 23:57 — mike kraft

A worldwide virus-hunting program allowed to expire last year by the Trump administration, just before the coronavirus pandemic broke out, will have a second life — whatever the outcome of the presidential election.

Joseph R. Biden Jr. has promised that, if elected, he will restore the program, called Predict, which searched for dangerous new animal viruses in bat caves, camel pens, wet markets and wildlife-smuggling routes around the globe.

Country / Region Tags:

General Topic Tags: